cdc-gov/weekly-cumulative-estimated-number-of-rsv-a3gi-4phs
Icon for Socrata external plugin
  •  
    Overview
  •  
    Tables
  •  
    REST API
  •  
    SQL Query
Open repository in Console
 
Readme
Updated 12 months ago
‧
Indexed 11 months ago

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 Years and Older, United States

• Estimated Number of RSV vaccinations among adults 60 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices.

• Starting in September 2023, the CDC recommended the RSV vaccine for adults 60 years and older.

Querying over HTTP

Splitgraph serves as an HTTP API that lets you run SQL queries directly on this data to power Web applications. For example:

curl https://data.splitgraph.com/sql/query/ddn \
    -H "Content-Type: application/json" \
    -d@-<<EOF
{"sql": "
    SELECT *
    FROM \"cdc-gov/weekly-cumulative-estimated-number-of-rsv-a3gi-4phs\".\"weekly_cumulative_estimated_number_of_rsv\"
    LIMIT 100 
"}
EOF

See the Splitgraph documentation for more information.

 
Preview
  • weekly_cumulative_estimated_number_of_rsv
     
    Left sidebar is currently unimplemented
     
     
     
     
    Right sidebar is currently unimplemented
Upstream Metadata
Common CoreHomepagehttps://www.cdc.gov/vaccines/vaxview/index.htmlLanguageEnglishPublisherNational Center for Immunization and Respiratory Diseases (NCIRD)Bureau Code009:20Contact NameVaxView TeamProgram Code009:020Contact EmailVaxView@cdc.govUpdate FrequencyWeeklyGeographic CoverageUnited States- National Temporal Applicability2023-2024
Data QualityFootnotesThe projected pharmacy estimates are based on IQVIA LRx product (https://www.iqvia.com/insights/the-iqvia-institute/available-iqvia-data) and vaccinations administered in retail pharmacies (including chain, mass merchandise, food stores, and independent pharmacies). The estimates include RSV vaccinations that were billed to insurers (i.e. claims) or paid by cash. Evaluations are underway to determine average time-lag for claims and data processing for RSV vaccinations; for comparison purposes, initial evaluation of IQVIA flu vaccination estimates is available at https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-administered.html and indicates that the reported number of doses administered for a particular week increased over the next few weeks. The projected physician medical offices estimates are based on IQVIA’s Dx product (https://www.iqvia.com/insights/the-iqvia-institute/available-iqvia-data). The estimates include RSV vaccinations that are claims-based only, and estimates are expected to increase over time for a given time period as claims are processed and adjudicated. Evaluations are underway to determine average time-lag for claims and data processing for RSV vaccinations; for comparison purposes, initial evaluation of IQVIA flu vaccination estimates is available at https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-administered.html and indicates that the reported number of doses administered for a particular week increased over the next few weeks. Vaccinations administered in other settings such as workplaces and community settings are not included in these data. National estimates for pharmacies and medical offices include vaccinations administered in 50 states and the District of Columbia. National estimates for medical office vaccinations do not include doses where geographic information (i.e. which state the dose was administered in) was missing. Pharmacy data are through Friday of each week and medical office data are through Saturday of each week. King, L. M., Bartoces, M., Fleming-Dutra, K. E., et al. (2020). Changes in US outpatient antibiotic prescriptions from 2011–2016. Clinical Infectious Diseases, 70(3), 370-377. ‡McLaughlin, J. M., Swerdlow, D. L., Khan, F., et al. (2019). Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States. Human vaccines & immunotherapeutics, 15(4), 841-849.Suggested CitationNational Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention. Weekly Cumulative Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 Years and Older, United States. Geospatial ResolutionNational, State

About

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States
12 months ago (updated)
11 months ago (indexed)
Loading...

Topics

  • adults
  • iqvia
  • rsv vaccination

Sources

License

Public Domain U.S. Government